(EMSG) DBX Trust - Xtrackers MSCI - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330512268

EMSG: Equity, Securities, ESG, Emerging, Leaders

The DBX ETF Trust - Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF (EMSG) is an exchange-traded fund that tracks a subset of the MSCI ACWI Select Climate500 Index, focusing on emerging markets companies that demonstrate strong ESG (Environmental, Social, and Governance) leadership. By investing at least 80% of its assets in component securities of the underlying index, the fund provides exposure to a curated selection of emerging markets stocks that are expected to outperform their peers in terms of climate and ESG metrics.

Given its non-diversified nature, EMSG is likely to be more sensitive to sector-specific trends and company-specific risks. However, its focus on ESG leaders may also provide a degree of resilience to environmental and social risks. The funds underlying index is designed to capture the performance of approximately 500 stocks, providing a relatively broad coverage of the emerging markets universe.

From a technical analysis perspective, EMSGs recent price action suggests a bullish trend, with the last price of $29.64 exceeding both the 20-day and 50-day simple moving averages (SMA20 and SMA50). The stock is also trading near its 52-week high, indicating strong momentum. The average true range (ATR) of 0.50, or 1.70%, suggests moderate volatility. Considering these technical indicators, a potential forecast is that EMSG may continue to trend upwards, potentially reaching new 52-week highs in the near term.

Fundamentally, EMSGs assets under management (AUM) stand at $198.54 million, indicating a relatively modest but still significant investor base. As the fund continues to attract investors seeking ESG-focused emerging markets exposure, its AUM is likely to grow. Combining this fundamental insight with the technical analysis, a potential forecast is that EMSG may experience sustained inflows, driving its price higher and potentially reaching $31.50 within the next 6-12 months, representing a 6-7% upside from current levels.

Additional Sources for EMSG ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EMSG ETF Overview

Market Cap in USD 303m
Category Diversified Emerging Mkts
TER 0.20%
IPO / Inception 2018-12-04

EMSG ETF Ratings

Growth Rating 10.2
Fundamental -
Dividend Rating 6.10
Rel. Strength 6.97
Analysts -
Fair Price Momentum 29.74 USD
Fair Price DCF -

EMSG Dividends

Dividend Yield 12m 0.86%
Yield on Cost 5y 1.03%
Annual Growth 5y -25.78%
Payout Consistency 62.7%
Payout Ratio %

EMSG Growth Ratios

Growth Correlation 3m 91.2%
Growth Correlation 12m 63%
Growth Correlation 5y -36.9%
CAGR 5y 5.19%
CAGR/Max DD 5y 0.11
Sharpe Ratio 12m 0.44
Alpha 10.23
Beta 0.753
Volatility 16.50%
Current Volume 7513.3k
Average Volume 20d 3.2k
What is the price of EMSG shares?
As of July 01, 2025, the stock is trading at USD 31.36 with a total of 7,513,333 shares traded.
Over the past week, the price has changed by +3.74%, over one month by +7.32%, over three months by +12.49% and over the past year by +22.12%.
Is DBX Trust - Xtrackers MSCI a good stock to buy?
Neither. Based on ValueRay´s Analyses, DBX Trust - Xtrackers MSCI is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 10.23 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMSG is around 29.74 USD . This means that EMSG is currently overvalued and has a potential downside of -5.17%.
Is EMSG a buy, sell or hold?
DBX Trust - Xtrackers MSCI has no consensus analysts rating.
What are the forecasts for EMSG share price target?
According to our own proprietary Forecast Model, EMSG DBX Trust - Xtrackers MSCI will be worth about 34.2 in July 2026. The stock is currently trading at 31.36. This means that the stock has a potential upside of +9.15%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 34.2 9.2%